The Filing Desk

Niagen Bioscience vs Nature's Sunshine Products

Niagen Bioscience NAGE · Nature's Sunshine Products NATR · Personal Care Products

Nature's Sunshine Products reported revenue of $480 million in fiscal 2025, 3.7 times Niagen Bioscience's $129 million in fiscal 2025. Niagen Bioscience's revenue grew 29.9% in its latest year, and Nature's Sunshine Products' grew 5.7%. Niagen Bioscience had an operating margin of 12.6%, against 5.2% at Nature's Sunshine Products.

Side by side

Niagen BioscienceNature's Sunshine Products
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$129M$480M
Revenue growth29.9%5.7%
Revenue growth a year, last 5 years16.9%4.5%
Gross margin64.3%72.4%
Operating margin12.6%5.2%
Net margin13.4%4.1%
Free cash flow—$29M
Free cash flow margin—6.0%
Return on capital—23.6%
Net debt to EBITDA−3.8x−2.4x
Dividends and buybacks$0M$16M
Change in diluted share count9.4%−3.2%
Last close$2.06$10.36
P/E at the last close17.2×12.6×
Insider trades, last 12 monthsbought $45,616, sold $0bought $5.5 million, sold $1.9 million
Piotroski F-score6 of 97 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Niagen BioscienceNature's Sunshine Products
Operating margin
Percent of revenue
Niagen BioscienceNature's Sunshine Products
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Niagen BioscienceNature's Sunshine Products

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Niagen Bioscience and Nature's Sunshine Products pages.